1. Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. (16th April 2018) Authors: Sorosina, M.; Clarelli, F.; Ferrè, L.; Osiceanu, A. M.; Unal, N. T.; Mascia, E.; Martinelli, V.; Comi, G.; Benigni, F.; Esposito, F.; Martinelli Boneschi, F. Journal: European journal of neurology Issue: Volume 25:Number 7(2018) Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗